New Study Identifies Formula LP As Most Effective Immune Booster Available in Market
Posted on: Tuesday, 28 October 2008, 09:00 CDT
Cold and Flu Response, LLC (www.ColdAndFluResponse.com), the maker of Formula LP, announced today the results of a recent study conducted at the University of Alberta Medical School to determine the effectiveness of commercial immune boosting products. When cultured lymphocytes were exposed to Formula LP, they responded with a greater growth rate than the control, while the rest of the products did not exhibit significant growth. With respect to fighting potential bacterial and viral infections, lymphocyte proliferation is a good measure of immune response; none of the other products demonstrated this activity. The study concluded that Formula LP significantly out-performs the leading products in the Immune category.
According to Dr. Tod Kimbell, Vice President of Cold and Flu Response, "This is great news for consumers looking for an effective immune booster. Of the seven leading products tested in this category, only Formula LP was shown to significantly boost lymphocyte production, one of the body's principal defenses against invading germs, and a widely accepted measure of immune function in the medical community."
Immune boosters are used to protect people from a wide variety of microbial invaders that can contribute to colds, flu and other infections. Last year sales of immune boosters topped $700 million, as Americans turned to natural products in managing their well-being. "There is now clear scientific evidence to help consumers choose an effective immune booster and that evidence supports Formula LP," said Jim Bruce, President of Cold and Flu Response.
About Formula LP
Formula LP is a natural, immune-enhancing patented fraction of ginseng. This fraction of ginseng, unlike other commercial ginseng extracts, has been formulated to include only those active constituents clinically proven to enhance immune response. Increased lymphocyte production, specifically white blood cells, help increase the body's ability to fend off potential viral and bacterial infections and decrease the severity of the symptoms from these infections. In scientific studies, Formula LP has been clinically proven to boost lymphocyte proliferation higher than any leading competitive immune enhancing products.
About Cold and Flu Response
Cold and Flu Response is a Boulder-based company with a management team with over 40 years experience in the natural products industry. Staff and advisors include medical doctors and leading researchers from medical and academic institutions through out the world. The company's lead product, Formula LP, is the result of years of research and testing comparable to the drug development process. Cold and Flu Response practices sustainable ginseng crop management and all ginseng is grown in North America. For more information, visit www.ColdandFluResponse.com.
Source: Business Wire
Related Articles
- Refusing Immunizations Puts Children at Increased Risk of Pertussis Infection, Kaiser Permanente Study Finds
- Ericom's Remote Access and Business Continuity Solution Increases Immunity to Productivity Losses -- Combats Swine Flu Scare
- Link Confirmed Between Common Cold And Ear Infection
- I-Flow Leads Infection Prevention Trend By Using Silver With Antimicrobial Properties in Medical Devices
- The Immune Response Corporation Announces That Phase II Preliminary Data Indicate Investigative HIV Immunotherapy IR103 Enhances Immune Responses in Antiretroviral Naive HIV-Infected Patients
- Finisar Launches Production of DWDM SFP Transceivers, Leading the Industry in Power Consumption and RoHS Compliance
- Breakthrough Anti-Cold, Anti-Flu Product Cuts Recurrent Colds By More Than Half. Study Results of COLD-fX'R' to Be Published Tuesday
- The Immune Response Corporation and Oregon Health & Science University Collaboration Identifies FOXP3 As the Gene Marker for Impaired Immune Regulation in Multiple Sclerosis; Results May Lead to a New Therapeutic Approach to Treating MS
- Genasense(R) Significantly Increases Major Responses in Patients With Advanced Chronic Lymphocytic Leukemia
- Lancaster, Pa., Residents Rush to Buy Flu, Cold Medicine Praised on 'Oprah'
 |
 |
User Comments (0)
RSS Feeds